News & Events


DIA 2016 Recap

DIA 2016 Recap
18 August 2016

We returned reenergized from the 52nd Annual DIA Meeting in Philadelphia, whose theme was “A Gathering of Global Perspectives”. This year’s meeting did seem to have strong international attendance, with nearly 8,000 scientists, clinicians, students, investors and industry experts from around the world in attendance. Patient centricity was top of mind, as was innovative or disruptive use of technology to drive greater efficiencies as globalization of clinical trials continues. Patient recruitment remains a hot button, with site strategies and use of big data much discussed and debated as a means of increasing access to patients and lowering costs.

We had the opportunity to meet up with clients and prospective clients to learn and discuss trends and subjects related to the current and future state of clinical development. The focus of our interactions centered around understanding the challenges our customers face in running increasingly complex, global trials, and aligning our expertise to support them. The needs of innovative drug and device developers were diverse and we found our conversations engaging and enlightening.

Dr. Stephan de la Motte, the company’s chief medical advisor, participated in a very well attended panel discussion on “Rare Disease Clinical Trials: Coping with Unique Challenges”. He was able to speak further with several people at our booth afterwards to provide even more of his expert insight on the topic. And we were pleased to have our scientific, regulatory and operational experts on hand to converse with visitors about core challenges and solutions for immunotherapy research, the impact of the new EU Clinical Trials regulation being implemented and the nuances of running pediatric trials mandated by the FDA.

We look forward to DIA 2017 in Chicago, and continuing to be a part of this dynamic and thought provoking event.


Contact Synteract

Tell us how to stay in touch with you: